Sign up
Pharma Capital

eSense-Lab expands partnerships

The halt will remain in place until Monday 15th January 2018.
1515627513_handshake-888542.jpg
The company's shares are in pre-open

eSense-Lab Ltd (ASX:ESE) is preparing to outline a material sales and distribution commercial agreement, and the ASX has granted the company a trading halt to finalise.

The company recently entered the Australian beer market, through a deal with Young Henry’s Brewing Company Pty for the development of a terpene infused line of beer.

Terpenes are organic compounds found in plants responsible for flavour and fragrance.

The halt will remain in place until the opening of trade on Monday 15th January 2018, or earlier if an announcement is made to the market.

View full ESE profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.